Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Childs Nerv Syst ; 37(1): 101-105, 2021 01.
Article in English | MEDLINE | ID: mdl-32980920

ABSTRACT

PURPOSE: Intraventricular neuroendoscopic techniques, particularly third ventriculostomy, are employed increasingly in the management of infantile hydrocephalus. However, surgical access to the ventricular cavities is associated with a risk of post-operative cerebrospinal fluid (CSF) leak. Here, we describe a structured, multi-layered approach to wound opening and closure which aims to maximise the natural tissue barriers against CSF leakage. We present a series of patients undergoing this technique and subsequently review the literature regarding opening and closure techniques in paediatric intraventricular neuroendoscopic procedures. METHODS: We performed a retrospective case series analysis of patients under 1 year of age who underwent intraventricular neuroendoscopic procedures in a single institution over a 5-year period. Patients were identified from an institutional operative database, and operation notes and clinical records were subsequently reviewed. RESULTS: 28 patients fulfilled the inclusion criteria for this study. The mean age at operation was 9 weeks. 27 patients underwent endoscopic third ventriculostomy whilst 1 underwent endoscopic septostomy, and all patients underwent our structured, multi-layered opening and closure technique. Follow-up ranged from 4 months to 5 years. There were no cases of post-operative CSF leak, infection or wound breakdown. 12 patients remained shunt-free at the last follow-up, with the remaining 16 requiring shunt insertion for progressive hydrocephalus at a mean of 24 days post-operatively. CONCLUSION: Various methods aiming to prevent post-operative CSF leak have been reported in the literature. We propose that our institutional technique may be of benefit in minimising this risk in infants undergoing endoscopic third ventriculostomy and similar intraventricular neuroendoscopic procedures.


Subject(s)
Hydrocephalus , Neuroendoscopy , Third Ventricle , Child , Humans , Hydrocephalus/surgery , Infant , Neuroendoscopes , Retrospective Studies , Third Ventricle/surgery , Treatment Outcome , Ventriculostomy
3.
Br J Neurosurg ; 22(1): 135-6, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18224533

ABSTRACT

A baby was referred with torsion of a sacral appendage. The lesion was excised and the histology confirmed it to be a lipoma. Human tail is a rare presentation and torsion is a complication that has not been documented before.


Subject(s)
Lipomatosis/diagnosis , Spinal Dysraphism/diagnosis , Torsion Abnormality/surgery , Female , Humans , Infant , Lipomatosis/pathology , Male , Spinal Dysraphism/surgery , Treatment Outcome
4.
J Biol Chem ; 274(45): 31891-5, 1999 Nov 05.
Article in English | MEDLINE | ID: mdl-10542215

ABSTRACT

Na(+)-dependent transporters for glutamate exist on astrocytes (EAAT1 and EAAT2) and neurons (EAAT3). These transporters presumably assist in keeping the glutamate concentration low in the extracellular fluid of brain. Recently, Na(+)-dependent glutamate transport was described on the abluminal membrane of the blood-brain barrier. To determine whether the above-mentioned transporters participate in glutamate transport of the blood-brain barrier, total RNA was extracted from bovine cerebral capillaries. cDNA for EAAT1, EAAT2, and EAAT3 was observed, indicating that mRNA was present. Western blot analysis demonstrated all three transporters were expressed on abluminal membranes, but none was detectable on luminal membranes of the blood-brain barrier. Measurement of transport kinetics demonstrated voltage dependence, K(+)-dependence, and an apparent K(m) of 14 microM (aggregate of the three transporters) at a transmembrane potential of -61 mV. Inhibition of glutamate transport was observed using inhibitors specific for EAAT2 (kainic acid and dihydrokainic acid) and EAAT3 (cysteine). The relative activity of the three transporters was found to be approximately 1:3:6 for EAAT1, EAAT2, and EAAT3, respectively. These transporters may assist in maintaining low glutamate concentrations in the extracellular fluid.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Blood-Brain Barrier , Carrier Proteins/metabolism , Glutamic Acid/metabolism , Receptors, Neurotransmitter/metabolism , Symporters , Amino Acid Transport System X-AG , Animals , Biological Transport , Cattle , Excitatory Amino Acid Transporter 2 , Glutamate Plasma Membrane Transport Proteins , Kinetics , Models, Biological
SELECTION OF CITATIONS
SEARCH DETAIL